State-of-the-art facility will expand capacity for producing tissue-based and additional regenerative medicinesCAMBRIDGE, Mass. and BASEL, Switzerland, April 21, 2022 (GLOBE…
Clinical Data from one research site for GCC19CART, ICT’s lead solid tumor program, for 3rd line plus relapsed/refractory metastatic colorectal…
ROCKAWAY, N.J., April 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that…
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical…
BOCA RATON, Fla, April 21, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in…
BOTHELL, Wash., April 21, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces a Non-Clinical…
Topline data expected to be presented at a scientific conference in May 2022Independent data shows ~5.4M outpatient colonoscopies are performed…
Company expects preliminary estimated revenue to be $7.5 million Timothy Norris Irish appointed Chairman of the Board of Directors, successor…
Impel Celebrates Its One-Year Anniversary as a Public CompanySEATTLE, April 21, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a…
ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and…